Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -87.09% is 60% above its 5-year average of -217.34%, near the high end of its 5-year range (-674.08%–-87.09%).
33.10% above its 12-month average of -130.17%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -17.75%.
RETURN ON ASSETS (ROA)
-87.09%
RETURN ON ASSETS (ROA) AVG TTM
-130.17%
RETURN ON ASSETS (ROA) AVG 3Y
-272.35%
RETURN ON ASSETS (ROA) AVG 5Y
-217.34%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+33.10%
CURRENT VS 3Y AVG
+68.02%
CURRENT VS 5Y AVG
+59.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-24.95%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
-249.06%
vs the sector median at left
Cingulate Inc.
Market Cap
$63.98M
Return on Assets (ROA)
-87.09%
TTM Avg
-130.17%
3Y Avg
-272.35%
5Y Avg
-217.34%
Market Cap
$65.08M
Return on Assets (ROA)
-162.91%
TTM Avg
-58.42%
3Y Avg
-64.67%
5Y Avg
-61.98%
Market Cap
$66.56M
Return on Assets (ROA)
-39.17%
TTM Avg
-30.96%
3Y Avg
-31.81%
5Y Avg
-21.33%
Market Cap
$67.11M
Return on Assets (ROA)
-382.32%
TTM Avg
-98.02%
3Y Avg
-80.35%
5Y Avg
-65.77%
Market Cap
$60.48M
Return on Assets (ROA)
-66.80%
TTM Avg
-56.95%
3Y Avg
-50.95%
5Y Avg
-40.99%
Market Cap
$60.29M
Return on Assets (ROA)
-128.88%
TTM Avg
-89.84%
3Y Avg
-89.26%
5Y Avg
-80.42%
Market Cap
$69.05M
Return on Assets (ROA)
-3.41%
TTM Avg
5.09%
3Y Avg
-8.30%
5Y Avg
-5.06%
Market Cap
$69.43M
Return on Assets (ROA)
35.31%
TTM Avg
-14.11%
3Y Avg
-23.46%
5Y Avg
-20.68%
Market Cap
$58.43M
Return on Assets (ROA)
-37.05%
TTM Avg
-34.36%
3Y Avg
-41.63%
5Y Avg
-37.74%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cingulate Inc. (CING) | $63.98M | -87.09% | -130.17% | -272.35% | -217.34% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | -162.91% | -58.42% | -64.67% | -61.98% |
| Alps Group Inc (ALPS)vs › | $66.56M | -39.17% | -30.96% | -31.81% | -21.33% |
| PDS Biotechnology Corporation (PDSB)vs › | $67.11M | -382.32% | -98.02% | -80.35% | -65.77% |
| Adicet Bio, Inc. (ACET)vs › | $60.48M | -66.80% | -56.95% | -50.95% | -40.99% |
| Fractyl Health, Inc. (GUTS)vs › | $60.29M | -128.88% | -89.84% | -89.26% | -80.42% |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | -3.41% | 5.09% | -8.30% | -5.06% |
| Fortress Biotech, Inc. (FBIO)vs › | $69.43M | 35.31% | -14.11% | -23.46% | -20.68% |
| Boundless Bio, Inc. (BOLD)vs › | $58.43M | -37.05% | -34.36% | -41.63% | -37.74% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.01M | -99.89% | -66.19% | -52.51% | -39.81% |
ROA
-87.1%
ROE
-122.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -148.94% |
| 2024-12-31 | -111.40% |
| 2023-12-31 | -674.08% |
| 2022-12-31 | -154.99% |
| 2021-12-31 | -90.49% |
| 2020-12-31 | -124.12% |
| 2019-12-31 | -218.65% |
